NPCENeuroPace, Inc.
What is the market doing?
In a downtrend (−19% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 28). Price is −19% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How NPCE is trading
NeuroPace, Inc. is +16% over the past year while the S&P 500 is +18%: 2.1 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −19%
vs 200-day average · a clear downtrend
- RSI (14)
- 28
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 36%
Below its 52-week high
Details›
- Last close2026-10-08
- $12.37
- 1 monthS&P 500 +1.6%
- −15%
- 1 yearS&P 500 +18%
- +16%
- 5 yearsS&P 500 +86%
- −22%
- vs 50-day average$14.12
- −12%
- 52-week high
- $19.29
- 52-week low
- $9.40
- Annualised volatility
- 68%
| Year | Return |
|---|---|
| 2026 (year to date) | −20% |
| 2025 | +38% |
| 2024 | +8.5% |
| 2023 | +592% |
| 2022 | −85% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 3 of 5 | +51% |
| Feb | 5 | 2 of 5 | +1.5% |
| Mar | 5 | 1 of 5 | −7.5% |
| Apr | 5 | 2 of 5 | +5.5% |
| May | 6 | 1 of 6 | −12% |
| Jun | 6 | 3 of 6 | −4.3% |
| Jul | 6 | 2 of 6 | −6.7% |
| Aug | 6 | 4 of 6 | +20% |
| Sep | 6 | 2 of 6 | −6.5% |
| Oct | 6 | 0 of 6 | −13% |
| Nov | 5 | 3 of 5 | +16% |
| Dec | 5 | 3 of 5 | +1.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.